Literature DB >> 6856194

Total GABA and homocarnosine in CSF as indices of brain GABA concentrations.

M G Palfreyman, S Huot, J Grove.   

Abstract

Treatment of rats with gamma-vinyl-GABA, an inhibitor of GABA-transaminase, caused a dose- and time-related increase in brain GABA concentrations concomitant with increases in the concentrations of total GABA and homocarnosine in the CSF. At 18 h after treatment both CSF parameters correlated significantly with brain GABA concentrations. However, only total GABA in CSF accurately reflected brain GABA concentrations as a function of time after treatment and is therefore the preferred index.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6856194     DOI: 10.1016/0304-3940(83)90544-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.

Authors:  S M Grant; R C Heel
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

2.  Cerebrospinal fluid concentrations of free GABA in schizophrenia: no changes after haloperidol treatment.

Authors:  W F Gattaz; E Roberts; H Beckmann
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

3.  Effects of vigabatrin and of GABA on myelinated rat cerebellar cultures: preliminary data.

Authors:  J J Hauw; J M Boutry; P Sun; V Sazdovitch; C Duyckaerts
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.